|
Address
|
H. Lundbeck A/S
Ottiliavej 9
DK-2500 Valby - Copenhagen
Denmark
Tel: +45 3630 1311
Fax: +45 3643 8262
Â
|
|
Media Relations
|
Anders Schroll
Head of Corporate Communication
Tel: +45 3643 2081
Mobile: +45 3083 2081
asch@lundbeck.com
Jens Harder Højbjerg
Media Relations Manager
Tel:Â Â +45 3643 2833
Mob: +45 3083 2833
jehh@lundbeck.com
Mads Vindahl Kronborg
Communication Specialist
Tel:Â +45 3643 2851
Mob: +45 3083 2851
mavk@lundbeck.com
Â
|
|
Profile
|
 H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders.
Â
|
|
Board of Management
Â
|
Ulf Wiinberg, Chief Executive Officer
Anders Gersel Pedersen, Executive Vice President, Drug Development
Anders Götzsche, Executive Vice President, Chief Financial Officer
Lars Bang, Executive Vice President, Supply Operation, Engineering
Peter Høngaard Andersen, Executive Vice President, Research Management
Stig Løkke Pedersen, Executive Vice President, Commercial Operations
Â
|
|
Average number of employees
Â
|
2003Â Â 2004Â Â Â 2005Â Â Â 2006Â Â Â Â 2007
5,223Â Â 5,155Â Â 5,022Â Â 5,111Â Â Â 5,134
|
|
Revenue
Â
Â
|
DKK million
2003Â Â 2004Â Â 2005Â Â 2006Â Â Â 2007
9,941Â 9,733Â 9,070Â 9,221Â Â 10,985
|
|
Revenue by product
Â
|
Â
|
2007
|
|
Cipralex®/Lexapro®
Ebixa® Â
Azilect®
Other products  Â
Other revenue
|
62%
16%
 2%
17%
 3%
Â
|
|
Revenue by market
Â
|
Europe                          Â
USAÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
International Markets       Â
Other revenue                  Â
|
2007
51%
25%
21%
 3%
Â
|
Profit from operations
|
DKK million
2003Â Â 2004Â Â 2005Â Â Â 2006Â Â Â 2007
2,147Â 2,554Â 2,170Â Â 1,784Â Â 2,695
Â
|
| R&D costs |
DKK million   Â
2003Â Â 2004Â Â 2005Â Â 2006Â Â 2007
1,931Â 1,776Â 1,782Â 1,958Â 2,187
Â
|
|
% of revenue
|
19%Â Â Â 18%Â Â Â 20%Â Â Â 21%Â Â 20%
|
|